ACGNG Nutritional Supplementation Guide for GLP-1 Users

The following guide is also available for download in a PDF version: Click here to download the ACGNG Nutritional Supplementation Guide for GLP-1 Users


Introduction

GLP-1 receptor agonist medications have shown strong clinical benefits for weight loss and blood sugar control, but they often suppress appetite and reduce food volume. This leads many individuals to consume fewer calories— and by extension, fewer nutrients—over time.

Supplementation is not a substitute for a balanced diet. However, in the context of reduced appetite and intake, it serves as a critical safety net to help prevent nutrient deficiencies, support energy levels, reduce common side effects, and sustain wellness during GLP-1 therapy.

This guide outlines evidence-based recommendations for vitamins, minerals, and supportive nutrients that can complement your diet and help maintain nutritional adequacy while using GLP-1 medications.

1. Why Supplementation Is Needed

  • Appetite suppression and reduced food intake
  • Delayed gastric emptying affecting nutrient absorption
  • Common deficiencies in Vitamin B12, D, Folate, and Magnesium
  • Digestive side effects like nausea or constipation

2. Key Nutrients to Monitor

NutrientWhy It Matters
Vitamin B12Nerve function, energy, and red blood cell formation
Vitamin D3Bone health, immunity, mood regulation
IronPrevents anemia and fatigue
Folate (5-MTHF)Critical for metabolism and DNA repair
MagnesiumSupports digestion, muscle, and nerve function
Zinc & SeleniumImmune and thyroid health
CalciumEssential for bones and weight maintenance
B1, B6, BiotinEnergy metabolism and nervous system support
Probiotics & EnzymesMay improve digestion and reduce GI discomfort

3. Recommended Daily Intake Ranges

NutrientDaily Target Range*
Vitamin A900–1500 mcg RAE
Vitamin C300–1000 mg
Vitamin D325–75 mcg (1000–3000 IU)
Vitamin E15–30 mg
Vitamin K160–120 mcg
Thiamine (B1)10–25 mg
Riboflavin (B2)5–20 mg
Niacin (B3)20–50 mg
Vitamin B610–50 mg
Folate (5-MTHF)400–800 mcg DFE
Vitamin B12100–500 mcg
Biotin300–1000 mcg
Pantothenic Acid (B5)10–50 mg
Calcium250–500 mg
Magnesium200–400 mg
Zinc8–25 mg
Selenium55–200 mcg
Copper0.9–2 mg
Manganese1.8–5 mg
Iodine150 mcg
Molybdenum45 mcg
Ashwagandha**100–300 mg
Black Pepper Extract**5–10 mg
Probiotics1–10 billion CFU
Digestive Enzymes**50–250 mg

*Based on NIH, ODS, ASMBS, and clinical research
**Optional and used with supervision

4. Ingredient Justification

  • B-Vitamins: Energy production, mood regulation, and fatigue prevention
  • Vitamin D3: Supports bone health and immune modulation
  • Calcium & Magnesium: Critical for bones and digestive comfort
  • Zinc & Selenium: Key antioxidants and metabolic cofactors
  • Probiotics & Enzymes: Aid digestion and reduce GI side effects
  • Botanicals (optional): Ashwagandha and ginger may support stress and nausea relief

5. Summary Chart

CategoryNutrients
Essential VitaminsA, B1, B2, B3, B5, B6, B12, C, D3, E, K1, Folate
Core MineralsCalcium, Magnesium, Zinc, Selenium, Copper, Iodine, Manganese, Molybdenum
GI SupportDigestive Enzymes (e.g., Bromelain), Probiotics
Botanical SupportGinger Root, Ashwagandha, Black Pepper Extract

6. References

  1. American Society for Metabolic and Bariatric Surgery (ASMBS) Guidelines, 2020
  2. NIH Office of Dietary Supplements – Micronutrient Fact Sheets
  3. Jastreboff AM et al. “Tirzepatide for Obesity.” NEJM, 2022
  4. Holst JJ. “The physiology of GLP-1.” Physiol Rev. 2007
  5. Kushner RF et al. “Obesity Management with GLP-1 Receptor Agonists.” JCEM, 2020
  6. Mechanick JI et al. “Obesity & Nutritional Guidelines.” Endocr Pract. 2019
  7. O’Neil PM et al. “GI Tolerability of GLP-1s.” Diabetes Obes Metab. 2021

7. Disclaimer

This guide is provided for educational purposes only. It does not replace medical advice or treatment. Always consult a qualified healthcare provider before starting any supplement. The American Center for GLP-1 Nutritional Guidance does not endorse any specific product or supplement. All recommendations are based on independent clinical research and national guidelines.